CClinicalTrials.gg
Active, not recruitingNCT06494176Updated Mar 11, 2026

Virtual Reality Exposure for Dental Fear

An interventional study of neVR Fear the Dentist in Dental Fear, sponsored by New York University. Active, not recruiting at 1 site in United States. Open to participants aged 13 Years and older. Per ClinicalTrials.gov, last updated 2026-03-11.

Sponsored by New York University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
250
Allocation
Randomized
Ages
13 Years and older
Sex
All
01

Study summary

The purpose of this study is to compare an intervention for dental fear to the usual approach (i.e., whatever your dentist typically does to help you manage fear) in reducing patient fear and making dentist appointments more tolerable. The dental fear intervention (called neVR Fear the Dentist™) has two separate steps. Step 1 involves using a mobile app that is based on research-backed approaches to handling dental fear on your smartphone or device. Step 2 is a 1-hour self-administered virtual reality intervention to be completed in the dental office.

This is a randomized study. Participants will be randomized to either the intervention group or an active control.

Investigators hypothesize that participants in the intervention condition will show greater declines in self-reported dental fear and improved oral health-related quality of life during post-treatment and follow-up period.

02

Conditions studied

  • Dental Fear
03

In context

Lead sponsor

New York University is the lead sponsor of 120 studies on the registry; 32 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Be at least 13 years of age
  2. Report dental fear of 4 or higher on a scale of 0-10 on the Gatchel dental fear item
  3. Be able and willing to comply with study procedures
  4. Provide a signed and dated informed consent form
  5. Proficient in English because the intervention is in English
  6. Have access to a smartphone or tablet
  7. If self-referred, have a dental appointment already scheduled with their own dentist.
  8. If self-referred, live in the NYC metro area or are willing to travel to the NYU College of Dentistry.
  9. If self-referred, have access to an Oculus headset and live in the U.S.

Exclusion criteria

Exclusion Criteria:

  1. Uncorrected, severe, or profound hearing or visual impairment such as stereoscopy blindness or nystagmus
  2. Diagnosed with any of the following psychiatric conditions: Posttraumatic Stress Disorder (PTSD) due to dental trauma, Major Neurocognitive Disorder (Dementia), Schizophrenia, or Intellectual Disability
  3. Current diagnosis of a balance disorder, such as vertigo
  4. Lifetime history of cybersickness
  5. Previous history of epileptic seizures
  6. A history of cardiac problems
  7. Are in pain, require urgent care, or whose necessary treatment will be delayed by participating in the study
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
250 participants (estimated)

Study arms

  • Experimental
    VRET Intervention

    Behavioral: neVR Fear the Dentist

  • No intervention
    Active Control

Interventions

  • BehavioralneVR Fear the Dentist

    neVR Fear the DentistTM comprises two major evidence-based interventions. First is a self-administered eHealth app for CBT/ psychoeducation with exposure therapy - delivered via a mobile tablet - that can be completed anywhere. Second is a 1-hr virtual reality exposure treatment (VRET).

06

What researchers measure

Primary outcomes

  1. Reduction in dental fear

    Overall dental fear will be measured by the self-report Gatchel Dental Fear Item (Gatchel, 1987). This scale uses a one-item assessment of overall dental fear. Patients rate their dental fear on a scale of 0 = "None" to 10 = "High", with higher scores representing higher levels of fear.

    Time frame: Measure will be collected at baseline, immediately post-treatment, and 1-, 3-, and 6-months post treatment.

  2. Dental fear and anxiety

    Dental fear and anxiety will also be measured using the Index of Dental Fear and Anxiety (IDAF; Armfield, 2010), an 8-item patient-report survey. Responses range from 1 = "Disagree" to 5 = "Strongly Agree." Total scores range from 5 to 40 with higher scores representing more dental anxiety/fear.

    Time frame: Measure will be collected at baseline, immediately post-treatment, and 1-, 3-, and 6-months post treatment.

  3. Anticipatory dental fear

    Anticipatory dental fear will be measured via self-report using the Modified Dental Anxiety Scale (MDAS; Humphries et al., 1995), a 5-item scale. All items are rated on a 1-5 scale where 1 = "Not Anxious" and 5 = "Extremely Anxious," with total scores ranging from 5 to 25. Higher scores indicate higher dental anticipatory anxiety.

    Time frame: Measure will be collected at baseline, immediately post-treatment, and 1-, 3-, and 6-months post treatment.

07

Study locations

1 site
  • New York University
    New York, New York 10010, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06494176
Lead sponsor
New York University
Collaborators
Virtually Better, Inc.
Responsible party
Sponsor
First posted
Jul 10, 2024
Start date
Aug 9, 2024
Primary completion
Dec 2026 (estimated)
Completion
Dec 2027 (estimated)
Last update
Mar 11, 2026

Study contacts

Richard Heyman, PhD
principal investigator · New York University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion